Kühnel H, von Briesen H, Dietrich U, Adamski M, Mix D, Biesert L, Kreutz R, Immelmann A, Henco K, Meichsner C
Chemotherapeutisches Forschungsinstitut, Frankfurt, Federal Republic of Germany.
Proc Natl Acad Sci U S A. 1989 Apr;86(7):2383-7. doi: 10.1073/pnas.86.7.2383.
Human immunodeficiency virus type 2 (HIV-2)-related viruses were isolated from a Gambian dying of exclusively neurological disease (HIV-2D194) and from an asymptomatic Ghanian (HIV-2D205). Both strains exhibited properties of HIV-1 biological subtype c: they grew slowly and induced few or no syncytia but eventually produced high levels of particle-associated reverse transcriptase in cultures of fresh peripheral blood lymphocytes, and they established stable infection of T-lymphoma (HUT-78) and monocytic (U937) cell lines. Each produced even higher levels of reverse transcriptase when fresh human monocytes/macrophages were used as target cells. The viruses were molecularly cloned after a single passage in culture, in order to minimize in vitro selection of subtypes present in vivo. Restriction-site analysis showed heterogeneity within each isolate. Nucleotide sequence analysis of a portion of the HIV-2D194 genome revealed that it is a member of the prototypic HIV-2 family, displaying 13% divergence versus HIV-2ROD and HIV-2NIHZ, as compared to 9% divergence between HIV-2ROD and HIV-2NIHZ. In contrast, HIV-2D205 is the most highly divergent HIV-2 strain yet described: it is equidistant in relation between the known HIV-2 strains and the simian immunodeficiency virus isolates from rhesus macaque monkeys (23-25% divergence).
2型人类免疫缺陷病毒(HIV-2)相关病毒分别从一名仅死于神经系统疾病的冈比亚人(HIV-2D194)和一名无症状的加纳人(HIV-2D205)体内分离得到。这两种毒株均表现出HIV-1生物学亚型c的特性:它们生长缓慢,诱导形成的合胞体很少或没有,但最终在新鲜外周血淋巴细胞培养物中产生高水平的颗粒相关逆转录酶,并且它们能在T淋巴瘤(HUT-78)和单核细胞(U937)细胞系中建立稳定感染。当使用新鲜的人单核细胞/巨噬细胞作为靶细胞时,每种毒株产生的逆转录酶水平更高。为了尽量减少对体内存在的亚型进行体外选择,这些病毒在培养中传代一次后进行分子克隆。限制性酶切位点分析显示每个分离株内部存在异质性。对HIV-2D194基因组一部分的核苷酸序列分析表明,它是原型HIV-2家族的成员,与HIV-2ROD和HIV-2NIHZ相比有13%的差异,而HIV-2ROD和HIV-2NIHZ之间的差异为9%。相比之下,HIV-2D205是迄今描述的差异最大的HIV-2毒株:它与已知的HIV-2毒株以及恒河猴的猿猴免疫缺陷病毒分离株的差异程度相当(23%-25%的差异)。